Pronóstico y análisis del ETF FMED - Dividendos·Comisiones·Composición·NAV·RSI·MACD | US Stocks Hoy
Tabla completa
| Category | US Equities - Industry Sector | Expense | 0.5% | Return% 1Y | 20.64% | Total Holdings | 77 | Perf Week | 1.23% | Volume | 3,396 |
| Asset Type | Equities (Stocks) | AUM | $52M | Return% 3Y | 14.34% | NAV | $32.07 | Perf Month | 0.1% | Avg Volume | 0.01M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | - | 52W High | -4.14% | Perf Quarter | 11.52% | Rel Volume | 0.47 |
| Active/Passive | Active | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 34.66% | Perf Half Y | 25.57% | Prev Close | $31.99 |
| IPO | 2023/6/12 | Flows% 1M | 0% | Return% SI | 7.4% | RSI (14) | 51.93 | Perf YTD | 16.89% | Price | $31.62 |
| Beta | 0.77 | Flows% 3M | 0% | Flows% YTD | -24.8% | Flows% 1Y | -21.65% | Perf Year | 19.9% | Volatility(W/M) | 2.49% 2% |
| SMA20 | 0.42% | SMA50 | 0.05% | SMA200 | 14.42% | ATR | 0.71 | ||||
Fidelity Disruptive Medicine ETFFMED | NASD | Gestión activa Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.
Las 10 mayores suman el 40% del fondo
LFST LIFESTANCE HEALTH GROUP INC 4.27% 4 
DHR DANAHER CORP 3.42% 5 
TXG 10X GENOMICS INC 3.11% 6 
ISRG INTUITIVE SURGICAL INC 2.92% 7 
COGT COGENT BIOSCIENCES INC 2.85% 8 
ALNY ALNYLAM PHARMACEUTICALS INC 2.79% 9 
ARGX ARGENX SE 2.78% 10 
LEGN LEGEND BIOTECH CORP 2.29% Primero los sectores con más peso.
En el último año, se considera alta
Está 4% por debajo del máximo de 1 año.
Se negoció menos de lo habitual. Es el 47% de su volumen medio.
El rendimiento a largo plazo es prácticamente plano
Si hubieras comprado hace 3 años, tu rentabilidad hoy sería +50.6%.
Toca para ver los números
El precio se mueve mucho
En su peor momento (julio de 2023) cayó un 22% y tardó 120 días en recuperarse.
Toca para ver los números
No hay dividendo
Todavía no hay beneficios que repartir.
Sale mucho dinero
En el último año salió dinero equivalente al 21.6% de los activos.
Toca para ver los números
TECL Direxion Daily Technology Bull 3X ETF 5.9B 
BULZ MicroSectorsTM Solactive FANG Innovation 3X Leveraged ETNs 3.2B 
FNGU MicroSectors FANG+ 3X Leveraged ETNs 2.6B 
ROM ProShares Ultra Technology 2x Shares 1.3B 
FNGO MicroSectors FANG+Index 2X Leveraged ETNs 761M 
MAGS Roundhill Magnificent Seven ETF 0.3% 
GRNY Fundstrat Granny Shots US Large Cap ETF 0.75% 
ARKG ARK Genomic Revolution ETF 0.75% 
XLSR State Street US Sector Rotation ETF 0.7% 
SSUS Day Hagan Smart Sector ETF 0.76% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
